第79回免疫学セミナー
◆第79回免疫学セミナー◆
【演題】 Translational research on pancreatic β-cells for the treatment of diabetes
【講師】 Jun Shirakawa, MD, PhD
【所属】 Professor, Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University
【日時】 令和5年8月25日(金）16：00ー18：00
【場所】 健康医科学イノベーション棟105室
【Abstract】
The decline in β-cell mass due to the failure of β-cell compensation or the β-cell death is one cause of the development of both type 1 and type 2 diabetes. Therefore, elucidation of the mechanism by which an adaptive increase in β-cell mass through interorgan networks occurs in vivo will lead to the development of a cure for diabetes. The immune system is an emerging target as an important player in regulating β-cell function and mass. A remaining barrier for the treatment of human diabetes using β-cells is the differences between human and rodent islets. In this seminar, I will focus on the crosstalks between islets and other tissues that regulate adaptive β-cell proliferation for the treatment of diabetes considering the abovementioned issues.
詳細はこちらをご覧下さい。
問合せ先： 医学医療系・免疫学
渋谷 彰（ashibuya@md.tsukuba.ac.jp）
029-853-3281